Terapia Molecular y Celular

Jefe de Laboratorio: Dr. Osvaldo L. Podhajcer

Patentes

• “Monoclonal Antibodies for Cancer Therapy”. Patente USA 5.753.229; otorgada. Licenciada en parte.
• “Use of the SPARC gene for antimelanoma therapy”. Patente USA 7.067.495; otorgada y en trámite de licenciamiento.
• “Use of cytokines combination for cancer therapy”. Patente USA 10/373,456. Pendiente y licenciada.
• “A specific fragment of the SPARC gene promoter for driving heterologous gene expression”. Patente PCT/US2007/010196. Argentina P-060101724.  Pendiente y licenciada.
• “A specific fragment of the A33 gene promoter for driving heterologous gene expression in caner”. Patente PCT: 2007/127882. Argentina P 06 01 01725. Pendiente y licenciada.
• “A Reactive Oxygen Species synthetic promoter and its use. Patente PCT 2008/005327. Argentina P-070101837. Pendiente.
• “Methods and systems for diagnosis of non-central nervous system (CNS) diseases in CNS samples. Patente PCT US10/563049. European Patent Application No.: 04777581.2. Otorgada. Propiedad de Gentron LLC.
• “New Extracts of Deschampsia Antarctica Desv. with antineoplastic activity. Pendiente. Patente PCT: 2009/064480.

[ Volver ]